Adverse drug reactions - examples of detection of rare events using databases
- PMID: 25060360
- PMCID: PMC4594728
- DOI: 10.1111/bcp.12474
Adverse drug reactions - examples of detection of rare events using databases
Abstract
It is recognised that randomised controlled trials are not feasible for capturing rare adverse events. There is an increasing trend towards observational research methodologies using large population-based health databases. These databases offer more scope for adequate sample sizes, allowing for comprehensive patient characterisation and assessment of the associated factors. While direct causality cannot be established and confounders cannot be ignored, databases present an opportunity to explore and quantify rare events. The use of databases for the detection of rare adverse events in the following conditions, sudden death associated with attention deficit hyperactivity disorder (ADHD) treatment, retinal detachment associated with the use of fluoroquinolones and toxic epidermal necrolysis associated with drug exposure, are discussed as examples. In general, rare adverse events tend to have immediate and important clinical implications and may be life-threatening. An understanding of the causative factors is therefore important, in addition to the research methodologies and database platforms that enable the undertaking of the research.
Keywords: adverse drug reactions; attention deficit hyperactivity disorder; database; retinal detachment; sudden death; toxic epidermal necrolysis (TEN).
© 2014 The British Pharmacological Society.
Similar articles
-
Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in vietnamese spontaneous adverse drug reaction database: A subgroup approach to disproportionality analysis.J Clin Pharm Ther. 2019 Feb;44(1):69-77. doi: 10.1111/jcpt.12754. Epub 2018 Aug 20. J Clin Pharm Ther. 2019. PMID: 30129156
-
Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System.Epilepsia. 2018 Dec;59(12):2318-2324. doi: 10.1111/epi.14591. Epub 2018 Nov 5. Epilepsia. 2018. PMID: 30395352 Free PMC article.
-
Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study.BMJ Open. 2015 Nov 18;5(11):e010077. doi: 10.1136/bmjopen-2015-010077. BMJ Open. 2015. PMID: 26582407 Free PMC article.
-
Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective.Indian J Dermatol Venereol Leprol. 2016 Nov-Dec;82(6):603-625. doi: 10.4103/0378-6323.191134. Indian J Dermatol Venereol Leprol. 2016. PMID: 27716721 Review.
-
[Stevens-Johnson syndrome and toxic epidermal necrolysis--updates and innovations].Harefuah. 2010 Mar;149(3):186-90, 193. Harefuah. 2010. PMID: 20684173 Review. Hebrew.
Cited by
-
Medication safety research by observational study design.Int J Clin Pharm. 2016 Jun;38(3):676-84. doi: 10.1007/s11096-016-0285-6. Epub 2016 Mar 22. Int J Clin Pharm. 2016. PMID: 27003827 Free PMC article. Review.
-
The role of in vitro testing in pharmacovigilance for ß-lactam-induced serum sickness-like reaction: A pilot study.Front Pharmacol. 2022 Aug 30;13:945545. doi: 10.3389/fphar.2022.945545. eCollection 2022. Front Pharmacol. 2022. PMID: 36110527 Free PMC article.
-
Safety of fluoroquinolones.Rev Esp Quimioter. 2024 Apr;37(2):127-133. doi: 10.37201/req/143.2023. Epub 2023 Dec 22. Rev Esp Quimioter. 2024. PMID: 38140798 Free PMC article. Review.
-
Hospitalizations and adverse drug events in the Brazilian unified health system: a ten-year retrospective analysis of routine data.Rev Saude Publica. 2022 Oct 10;56:86. doi: 10.11606/s1518-8787.2022056003913. eCollection 2022. Rev Saude Publica. 2022. PMID: 36228231 Free PMC article.
-
Administration of oral fluoroquinolone and the risk of rhegmatogenous retinal detachment: A nationwide population-based study in Korea.PLoS One. 2018 Apr 12;13(4):e0195563. doi: 10.1371/journal.pone.0195563. eCollection 2018. PLoS One. 2018. PMID: 29649310 Free PMC article.
References
-
- The Uppsala Monitoring Centre. 2013. WHO collaborating centre for international drug monitoring. Pharmacovigilance: definitions. January. Available at http://www.who-umc.org/graphics/27400.pdf (last accessed 21 July 2014)
-
- Berger S, Kugler JD, Thomas JA, Friedberg DZ. Sudden cardiac death in children and adolescents: introduction and overview. Pediatr Clin North Am. 2004;51:1201–1209. - PubMed
-
- Gould M, Walsh B, Munfakh J, Kleinman M, Duan N, Olfson M, Greenhill L, Cooper T. Sudden death and use of stimulant medications in youths. Am J Psychiatry. 2009;166:992–1001. - PubMed
-
- McCarthy S, Cranswick N, Potts L, Taylor E, Wong IC. Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment. Drug Saf. 2009;32:1089–1096. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical